Mucormycosis not uncommon in India: Studies
The Hindu
A study from 2013-2015 at four major tertiary care hospitals in India reported 388 mucormycosis cases
Mucormycosis, or the grimmer popular name, “black fungus”, has evoked public concern in the context of the COVID-19 pandemic but the disease isn’t that uncommon, medical literature from India shows. A study from 2013-2015 at four major tertiary care hospitals in India reported 388 mucormycosis cases, nearly 56% of whom were reported as having “uncontrolled diabetes”. The next biggest risk factor was “trauma”, and reported in only 10% of the cases, which underlines the critical link of the disease to diabetes. The analysis, undertaken by medics at Post Graduate Institute of Medical Education and Research, Chandigarh also found a greater proportion of the fungal infection in north India along with higher mortality, says the study that appeared in June 2019 edition of Medical Mycology, an Oxford University Press journal. India has among the highest global prevalence of diabetes with about 9% of India’s adult population estimated to be diabetic according to the World Health Organization.More Related News